von Grabowiecki Yannick, Phatak Vinaya, Aschauer Lydia, Muller Patricia A J
Tumour Suppressors Group, Cancer Research United Kingdom (UK) Manchester Institute, The University of Manchester, Macclesfield, United Kingdom.
Medical Research Council (MRC) Toxicology Unit, Cambridge, United Kingdom.
Front Oncol. 2021 Dec 21;11:804107. doi: 10.3389/fonc.2021.804107. eCollection 2021.
Rab11-FIP1 is a Rab effector protein that is involved in endosomal recycling and trafficking of various molecules throughout the endocytic compartments of the cell. The consequence of this can be increased secretion or increased membrane expression of those molecules. In general, expression of Rab11-FIP1 coincides with more tumourigenic and metastatic cell behaviour. Rab11-FIP1 can work in concert with oncogenes such as mutant p53, but has also been speculated to be an oncogene in its own right. In this perspective, we will discuss and speculate upon our observations that mutant p53 promotes Rab11-FIP1 function to not only promote invasive behaviour, but also chemoresistance by regulating a multitude of different proteins.
Rab11-FIP1是一种Rab效应蛋白,参与细胞内吞区室中各种分子的内体循环和运输。其结果可能是这些分子的分泌增加或膜表达增加。一般来说,Rab11-FIP1的表达与更具致瘤性和转移性的细胞行为一致。Rab11-FIP1可以与癌基因如突变型p53协同作用,但也有人推测它本身就是一种癌基因。从这个角度出发,我们将讨论并推测我们的观察结果,即突变型p53通过调节多种不同蛋白质来促进Rab11-FIP1的功能,不仅促进侵袭行为,还促进化疗耐药性。